http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DO-P2014000240-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f52c68e4149a6c462b850d4e7cc2b2f9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0039
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F6-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
filingDate 2014-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bd623a35ea0dd2cf49b2131a2a1a217
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8eabc9064b1cbfb2b14600de8a72ed9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ad0df2e8080d0f42715b32ddeeb3a17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2662fb48b6fc8ae7a1bfea2b4e448833
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f86d2311b72e6296bcf76d34e378bce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9aafcd875c455febfc360a29e53567dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91aa50bb81644f7b70db6e2c9ea5ee0d
publicationDate 2015-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DO-P2014000240-A
titleOfInvention USE OF 18-METIL-15B, 16B-methylene-19-NOR-20-ESPIROX-4-EN-3-ONAS IN THE TREATMENT OF MENORRAGY, AND INTRAUTERINE SYSTEMS THAT INCLUDE 18-METIL-15B, 16B-methylene-19- NOR-20-ESPIROX-4-EN-3-ONAS FOR THE TREATMENT OF UTERINE BLEEDING DISORDERS
abstract Intrauterine use of 18-methyl-15ß, 16ß-methylene-19-nor-20-espirox-4-en-3-ones of general formula (1) formula (1) wherein R6 and R7 are hydrogen or a methylene group, for the treatment of menorrhagia, of intrauterine hemorrhages in general, and an intrauterine system for said use, comprising a compound of formula 1.
priorityDate 2012-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393625
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783

Total number of triples: 26.